Debut Plus

₹39.55

▲ +1.85 +4.91%

17 Jul 2026

NSE Listed · Pharmaceuticals

Onyx Biotec Limited (ONYX)

Volume: 8,000Avg Vol 1W: 6,400Avg Vol 1M: 1,53,36452W Range:₹24.2₹53.9
NSE BSE www.onyxbiotec.com
Key Ratios
Checked just now
Market Cap—
Current Price₹39.55
Previous Close₹37.7
High / Low (52w)₹53.9 / ₹24.2
Volume8,000
Avg Vol (1W)6,400
Avg Vol (1M)1,53,364
Stock P/E21.25
Book Value₹30.56
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹-0.12
P/B1.29
Debt / Equity0.53
50 DMA₹37.15
200 DMA₹38.19
Day change+4.91%
Price Chart
₹39.55▼ 22.45% · 1Y
₹56₹2923.8L
2025-07-17
2026-07-16

20-day avg volume: 1.7L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 17% YoY.
  • Net profit is growing year over year.
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025
Revenue₹45 Cr₹40 Cr₹54 Cr₹63 Cr
EBITDA₹4 Cr₹3 Cr₹7 Cr₹8 Cr
Net Profit₹3 Cr₹2 Cr₹4 Cr₹5 Cr
EPS2.841.563.053.31
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹37 Cr₹59 Cr₹74 Cr₹91 Cr
Total Liabilities₹20 Cr₹41 Cr₹49 Cr₹36 Cr
Equity₹16 Cr₹18 Cr₹25 Cr₹56 Cr
Total Debt————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹2 Cr₹2 Cr₹1 Cr
Investing₹-6 Cr₹-23 Cr₹-3 Cr₹1 Cr
Financing₹5 Cr₹16 Cr₹3 Cr₹5 Cr
Free Cash Flow₹0 Cr₹2 Cr₹2 Cr₹1 Cr
Shareholding
Promoter 65.1% Institutions 3.46% Public 31.44%
Efficiency & Working Capital
ROCE12.2%
Interest Coverage3.7
Dividend Payout—
Debtor Days119 d
Inventory Days95 d
Payable Days99 d
Cash Conversion Cycle115 d
Working Capital Days214 d
Shareholding Details

As of 2026-03-31

Promoter65.1%
FII1.1%
DII2.4%
Institutions3.5%
Public31.4%
Promoter Pledge0%
No. of Shareholders586
Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

PeriodNov 2024Nov 2024Mar 2025Sept 2025Mar 2026
Promoters65.1%65.1%65.1%65.1%65.1%
FIIs8.7%8.7%5.4%2%1.1%
DIIs0%0%0%0%2.4%
Public26.1%26.1%29.5%33%31.4%
Promoter Pledge0%0%0%0%0%
No. of Shareholders1,1811,181551640586
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Naresh KumarShareholding of Promoter and Promoter Group24%43,47,000
Sanjay JainShareholding of Promoter and Promoter Group21.5%38,94,600
Fateh Pal SinghShareholding of Promoter and Promoter Group19.6%35,61,600
Invicta Continuum Fund IPublic Shareholding2.4%4,34,000
Apneet KahlonPublic Shareholding1.7%3,00,000
Prognosis Securities Private LimitedPublic Shareholding1.5%2,76,000
Invicta CapservPublic Shareholding1.5%2,75,000
Kadayam Ramanathan BharatPublic Shareholding1.1%2,00,000
Harsh MahajanShareholding of Promoter and Promoter Group0%0
Lakshya JainShareholding of Promoter and Promoter Group0%0
Parmjeet KaurShareholding of Promoter and Promoter Group0%0
Meenu JainShareholding of Promoter and Promoter Group0%0
Darshan Kumar JainShareholding of Promoter and Promoter Group0%0
Devinder JainShareholding of Promoter and Promoter Group0%0
Neelam JainShareholding of Promoter and Promoter Group0%0
Anita MahajanShareholding of Promoter and Promoter Group0%0
Ramesh KumarShareholding of Promoter and Promoter Group0%0
Raj KumarShareholding of Promoter and Promoter Group0%0
Ashok BalaShareholding of Promoter and Promoter Group0%0
Riya ChadhaShareholding of Promoter and Promoter Group0%0
Ram PiariShareholding of Promoter and Promoter Group0%0
Rekha GulatiShareholding of Promoter and Promoter Group0%0
Mehak Sood WaliaShareholding of Promoter and Promoter Group0%0
Marshal AhluwaliaShareholding of Promoter and Promoter Group0%0
Rideybir Singh WaliaShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sanjay Jain00%2026-03-31
Naresh Kumar00%2026-03-31
Fateh Pal Singh00%2026-03-31
Harsh Mahajan00%2026-03-31
Lakshya Jain00%2026-03-31
Parmjeet Kaur00%2026-03-31
Meenu Jain00%2026-03-31
Darshan Kumar Jain00%2026-03-31
Devinder Jain00%2026-03-31
Neelam Jain00%2026-03-31
Anita Mahajan00%2026-03-31
Ramesh Kumar00%2026-03-31
Board of Directors
NameDesignationYear
Sanjay JainExecutive Director & MD2025
Harsh MahajanExecutive Director / Whole Time Director / CFO2025
Naresh KumarE D & Wholetime Director2025
Lakshya JainE D & Wholetime Director2025
Parmjeet KaurNon-Exec & Non-Independent Dir2025
Prince Preet SinghIndependent Director2025
Vineet SinghIndependent Director2025
Nitesh GargIndependent Director2025
Ruchi ChowdhuryCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Pharmaceutical Pro₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10201818
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000202
2025000101
2025000101
Company Information
Incorporated2005
AuditorR C A & Co LLP
Investor Email[email protected]
🌐 www.onyxbiotec.com ↗

📍 Bir Plassi Near Sainimajraropr, Nalagarh Rd Dist Solan, Solan, Himachal Pradesh, 174101

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Onelife Cap Advisors Ltd.One Point One Sol Ltd.Onesource Specl Pharma LimitedOil And Natural Gas Corp.OnMobile Global Ltd.Onward Technologies Ltd.Optiemus Infracom Ltd.Optivalue Tek Consult Ltd.Orbit Exports LimitedOrchasp LimitedOrchid Pharma LimitedOriana Power LimitedAll “O” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search